0001209191-23-046246.txt : 20230817
0001209191-23-046246.hdr.sgml : 20230817
20230817161202
ACCESSION NUMBER: 0001209191-23-046246
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230815
FILED AS OF DATE: 20230817
DATE AS OF CHANGE: 20230817
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brownie William
CENTRAL INDEX KEY: 0001827381
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39616
FILM NUMBER: 231182000
MAIL ADDRESS:
STREET 1: C/O EARGO, INC.
STREET 2: 2665 NORTH FIRST STREET, SUITE 300
CITY: SAN JOSE
STATE: CA
ZIP: 95134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eargo, Inc.
CENTRAL INDEX KEY: 0001719395
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 273879804
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2665 NORTH FIRST STREET
STREET 2: SUITE 300
CITY: SAN JOSE
STATE: CA
ZIP: 95134
BUSINESS PHONE: 650-351-7700
MAIL ADDRESS:
STREET 1: 2665 NORTH FIRST STREET
STREET 2: SUITE 300
CITY: SAN JOSE
STATE: CA
ZIP: 95134
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-08-15
0
0001719395
Eargo, Inc.
EAR
0001827381
Brownie William
C/O EARGO, INC.
2665 NORTH FIRST STREET, SUITE 300
SAN JOSE
CA
95134
0
1
0
0
Interim CEO & COO
0
Common Stock
2023-08-17
4
S
0
14
3.23
D
8279
D
Common Stock
2023-08-17
4
S
0
1500
3.204
D
6779
D
Stock Option (Right to Buy)
3.305
2023-08-15
4
A
0
112500
0.00
A
2033-08-14
Common Stock
112500
112500
D
Stock Option (Right to Buy)
3.305
2023-08-15
4
A
0
93750
A
2033-01-31
Common Stock
93750
93750
D
Stock Option (Right to Buy)
11.58
2023-08-15
4
D
0
93750
D
2033-01-31
Common Stock
93750
0
D
Stock Option (Right to Buy)
3.305
2023-08-15
4
A
0
93750
A
2033-01-31
Common Stock
93750
93750
D
Stock Option (Right to Buy)
11.58
2023-08-15
4
D
0
93750
D
2033-01-31
Common Stock
93750
0
D
Stock Option (Right to Buy)
3.305
2023-08-15
4
A
0
825
A
2031-01-28
Common Stock
825
825
D
Stock Option (Right to Buy)
1051.60
2023-08-15
4
D
0
825
D
2031-01-28
Common Stock
825
0
D
Reflects the number of shares of Common Stock that were sold to satisfy tax withholding requirements on vesting of restricted stock units pursuant to the Issuer's automatic sell to cover program, and does not represent a discretionary sale by the Reporting Person.
The Stock Option vests and becomes exercisable in 8 equal quarterly installments, with the first installment vesting on November 15, 2023, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date.
The Issuer cancelled the Stock Option in exchange for a new Stock Option having a lower exercise price.
The Stock Option vests and becomes exercisable as to 20% of the shares subject to the stock option on February 15, 2024 (the "Vesting Start Date"), with the remainder vesting in 16 equal quarterly installments thereafter until all of the shares subject to the stock option have vested and become exercisable on the fourth anniversary of the Vesting Start Date, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date.
The Stock Option vests and becomes exercisable in 8 equal quarterly installments, with the first installment vesting on November 15, 2023, provided, that, any unvested portion of the Stock Option shall vest and become exercisable upon attainment of a 360-day VWAP (volume-weighted average price) of $20.00 for the Issuer's Common Stock, in either case, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date.
The Stock Option vests and becomes exercisable in full upon attainment of a 360-day VWAP (volume-weighted average price) of $20.00 for the Issuer's Common Stock on or prior to February 15, 2028, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through such date.
The Stock Option shall vest and become exercisable with respect to 16 quarterly installments commencing on February 15, 2021, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date.
On January 17, 2023, the Issuer effected a 1-for-20 reverse stock split of its Common Stock (the "Reverse Stock Split"). These securities reflect the Reverse Stock Split.
/s/ Christy La Pierre, Attorney-in-Fact for William Brownie
2023-08-17